Drug intelligence / Profile preview

valsartan + celecoxib

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Valsartan + celecoxib is a combination of two small molecule drugs, each with distinct mechanisms of action. Valsartan is an angiotensin II receptor blocker (ARB) used primarily to manage hypertension, heart failure, and diabetic nephropathy by selectively blocking the angiotensin II type 1 receptor, leading to vasodilation and reduced blood pressure[5]. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor nonsteroidal anti-inflammatory drug (NSAID), used to treat pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, acute pain, menstrual symptoms, and familial adenomatous polyposis. It works by inhibiting COX-2 enzyme activity involved in prostaglandin synthesis[8][6]. There are no widely marketed or approved fixed-dose combinations of valsartan with celecoxib; their co-administration may occur off-label but can reduce the antihypertensive effect of valsartan and increase risk for kidney dysfunction[1].

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)AGTR1 (Angiotensin II Type-1 receptor)

Beyond the preview

Go deeper on valsartan + celecoxib.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on valsartan + celecoxib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call